Evidence map›Paper›PMID 35433598›Full record

ArticleFrontiers in public health2022

Prevalence and Risk Factors for HTLV-1/2 Infection in Quilombo Remnant Communities Living in the Brazilian Amazon.

Wandrey Roberto Dos Santos Brito, Greice de Lemos Cardoso-Costa, Lourival Marques Roland Junior, Keise Adrielle Santos Pereira, Felipe Teixeira Lopes, Bernardo Cintra Dos Santos, Aline Cecy Rocha de Lima, Isabella Nogueira Abreu, Carlos Neandro Cordeiro Lima, Sandra Souza Lima and 4 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 1 institution in 1 country.

Wandrey Roberto Dos Santos BritoLaboratory of Virology, Institute of Biological Sciences, Federal University of Pará, Belém, Brazil.
Greice de Lemos Cardoso-CostaPostgraduate Program in Biology of Infectious and Parasitic Agents, Institute of Biological Sciences, Federal University of Pará, Belém, Brazil.
Lourival Marques Roland JuniorPostgraduate Program in Biology of Infectious and Parasitic Agents, Institute of Biological Sciences, Federal University of Pará, Belém, Brazil.
Keise Adrielle Santos PereiraLaboratory of Virology, Institute of Biological Sciences, Federal University of Pará, Belém, Brazil.
Felipe Teixeira LopesLaboratory of Virology, Institute of Biological Sciences, Federal University of Pará, Belém, Brazil.
Bernardo Cintra Dos SantosLaboratory of Virology, Institute of Biological Sciences, Federal University of Pará, Belém, Brazil.
Aline Cecy Rocha de LimaLaboratory of Virology, Institute of Biological Sciences, Federal University of Pará, Belém, Brazil.
Isabella Nogueira AbreuLaboratory of Virology, Institute of Biological Sciences, Federal University of Pará, Belém, Brazil.
Carlos Neandro Cordeiro LimaLaboratory of Virology, Institute of Biological Sciences, Federal University of Pará, Belém, Brazil.
Sandra Souza LimaLaboratory of Virology, Institute of Biological Sciences, Federal University of Pará, Belém, Brazil.
Izaura M Vieira Cayres VallinotoLaboratory of Virology, Institute of Biological Sciences, Federal University of Pará, Belém, Brazil.
Eduardo José Melo Dos SantosPostgraduate Program in Biology of Infectious and Parasitic Agents, Institute of Biological Sciences, Federal University of Pará, Belém, Brazil.
João Farias GuerreiroLaboratory of Human and Medical Genetics, Institute of Biological Sciences, Federal University of Pará, Belém, Brazil.
Antonio Carlos Rosário VallinotoLaboratory of Virology, Institute of Biological Sciences, Federal University of Pará, Belém, Brazil.
Universidade Federal do Pará · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human T-lymphotropic viruses 1 and 2 (HTLV-1 and HTLV-2) are retroviruses that originated on the African continent and dispersed throughout other continents through human migratory flows. This study describes the prevalence of HTLV-1 and HTLV-2 infection in residents of 11 quilombo remnant communities in the state of Pará, Brazil, and the associated risk factors. A total of 859 individuals (334 men and 525 women), aged between 7 and 91 years, participated in the study. All subjects answered a questionnaire with questions on sociodemographic characteristics and on risk factors associated with HTLV infection, and blood samples were collected and separated into plasma and leukocytes. An immunoenzymatic assay (ELISA; Murex HTLV-I+II, DiaSorin, Dartford, UK) was used as a screening test, and positive samples were subjected to line immunoassay confirmatory tests (Inno-LIA HTLV I/II Score FUJIREBIO) and DNA extraction for subsequent real-time PCR to differentiate the viral type. Four of the 859 individuals were seropositive for HTLV. HTLV-1 infection was confirmed in one individual from the Itamoari community (0.92%), and HTLV-2 infection was confirmed in two individuals from São Benedito (3.17%) and in one individual from Arimandeua (2.22%). Blood transfusion was the only risk factor associated with HTLV infection in this study. This study reports the occurrence of HTLV-1 and HTLV-2 in quilombo remnant communities in the state of Pará. Considering the African origin of the virus and its introduction into Brazil from the slave trade, the continued evaluation of quilombola communities in the state of Pará is essential to better characterize the distribution of infections in these populations and to create public health policies for the control of the spread of the virus and associated diseases.

Indexed as

HTLV-II InfectionsHTLV-I InfectionsHuman T-lymphotropic virus 1AdolescentAdultAgedAged, 80 and overBrazilChildFemaleHumansHuman T-lymphotropic virus 2MaleMiddle AgedPrevalenceRisk FactorsAmazonepidemiologyHTLV-1/2quilombosvulnerable population

Identifiers

PMID35433598
PMCPMC9005874
OpenAlexW4221084824

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.